most effective glp-1 for obesity treatment 2025 What is the pipeline future medications for obesity? GLP-1s reduce weight, with investigational

Administration of CDP Choline in animals increases phosphatidylcholine, noradrenaline, acetylcholine and dopamine levels

While conclusive human studies are limited, excessive or prolonged use of IGF-1 or IGF1-LR3 should be avoided to minimize potential oncogenic effects

Diabetic neuropathy: a narrative review of risk factors, classification, screening and current pathogenic treatment options (Review)

The reduction detected in the DCr and CrO+D groups compared with the control group was 39 and 41 %, respectively

PETER YOUNG, MEDICAL DIRECTOR Meet your medical team Peter Young, MD is the Medical Director for Nurxs Dermatology specialty

the most commonly reported adverse events in trials were gastrointestinal, including nausea, vomiting, and diarrhoea